|
RBM22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75381931200036E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62569957495862E-12 |
| Normal-vs-Stage2 |
7.64600000000559E-05 |
| Normal-vs-Stage3 |
4.35109999999961E-05 |
| Normal-vs-Stage4 |
4.810600E-04 |
| Stage1-vs-Stage2 |
4.219400E-01 |
| Stage1-vs-Stage3 |
1.099960E-02 |
| Stage1-vs-Stage4 |
7.482900E-03 |
| Stage2-vs-Stage3 |
3.310800E-01 |
| Stage2-vs-Stage4 |
2.101000E-01 |
| Stage3-vs-Stage4 |
7.378800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66133773404908E-12 |
| Normal-vs-AfricanAmerican |
2.108400E-02 |
| Normal-vs-Asian |
2.317400E-01 |
| Caucasian-vs-AfricanAmerican |
3.390100E-02 |
| Caucasian-vs-Asian |
7.038200E-01 |
| AfricanAmerican-vs-Asian |
6.697600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.62634358705327E-12 |
| Normal-vs-Female |
1.0677999595643E-09 |
| Male-vs-Female |
8.142400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.429800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.0393019778121E-11 |
| Normal-vs-Age(61-80Yrs) |
2.11449746601033E-11 |
| Normal-vs-Age(81-100Yrs) |
2.366400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.707000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.968030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.160800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.954600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.750200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.191800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.33969999538408E-08 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
2.99790003932543E-09 |
| Normal-vs-Grade 4 |
7.096300E-02 |
| Grade 1-vs-Grade 2 |
4.114600E-01 |
| Grade 1-vs-Grade 3 |
8.421700E-02 |
| Grade 1-vs-Grade 4 |
5.902700E-03 |
| Grade 2-vs-Grade 3 |
9.638700E-03 |
| Grade 2-vs-Grade 4 |
1.77281000000029E-05 |
| Grade 3-vs-Grade 4 |
1.388300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.442700E-03 |
| ccA subtype-vs-ccB subtype |
2.88991053309928E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51000323356243E-11 |
| Normal-vs-N1 |
5.738200E-01 |
| N0-vs-N1 |
4.516400E-02 |
|
|
